Rachana Lankapalli, MBBS, MPH

Dr. Rachana Lankapalli trained as a physician and received her MBBS Degree from Gandhi Medical College in Hyderabad, India. She also holds an MPH in Applied Epidemiology from the University of Arizona in Phoenix. Her professional experience includes working at the U.S. Food & Drug Administration along with working briefly in Johns Hopkins.

Dr. Lankapalli has a strong passion for teaching, having served as an Adjunct Faculty member at Howard Community College, where she taught Anatomy and Physiology to students planning to attend nursing/PA/PT/OT Schools/Pre-Med Students. She also facilitated Honors Seminars and was a faculty adviser for the Pre-Med and Pre-Allied Health Club. She also taught for the P.A. program at Anne Arundel Community College.

Courses Teaching:

• Physiology
• Anatomy

Professional Affiliation and Training:

• Fellowship, U.S. Food & Drug Administration
• Certificate course in Python Data Analysis
• Trained in statistical methods and I2E
• Attended Linguamatics Life Science and Healthcare NLP AI seminar
• Cancer Research at Johns Hopkins University

Research/Areas of Interest:

• Pharmacoepidemiology
• Clinical Trials
• Oncology Research
• Epidemiology Research
• Student Education Research

Peer-Reviewed Journal Publications/Poster Presentations:

• Li, J., Florian, J., Campbell, E., Schrieber, S.J., Bai, J.P., Weaver, J.L., Hyland, P.L., Thway, T.M., Matta, M.K., Lankapalli, R.H. and Narayanasamy, S., 2020. Advancing biosimilar development using pharmacodynamic biomarkers in clinical pharmacology studies. Clinical pharmacology and therapeutics, 107(1), p.40.
• Punyala, A., Lankapalli, R., Hindman, D. and Racz, R., 2020. Aggregation and analysis of indication-symptom relationships for drugs approved in the USA. European journal of clinical pharmacology, 76, pp.1291-1299.
• Drug information for older adults: A comparison between FDA product labels, UpToDate and Micromedex, Poster Presentation for Office of Clinical Pharmacology's OCP Science Day 2020. 
• Drug Safety in Women: Combining Post-Market Assessment and In Silico Modeling of Drug-Related Torsade de Pointes, Poster Presentation for Office of Women's Health 25th Anniversary 2019. 
• McAllister F, Bailey JM, Nirschl C, Jaffee EM, Lankapalli R, Maitra A, Sears C, Drake CM, Kolls JK, Pardoll DM and Leach SD. Oncogenic Kras activates an IL-17+ hematopoietic to epithelial signal axis in preinvasice pancreatic neoplasia. (Publication: Cancer Cell May 12 2014). • McAllister F, DeJesus A, Lankapalli R, Laheru D, Iacobuzio-Donahue C, Brodi J. dCK is a prognostic biomarker for pancreatic adenocarcinoma, not a predictive marker of response to gemcitabine. (Publication: Cancer Biology Therapeutics June 1 2014).
• McAllister F, Bailey J, Alsina J, Nirschl C, Lankapalli R, Roeser J, Jaffee E, Sears C, Kolls J, Drake C, Pardoll D, Leach S. TH17 cells promote early pancreatic tumorigenesis. AACR Annual Meeting 2013. Washington, DC. (April 2013).
• FJ Leyva, RH Lankapalli. Association Among Obstructive Sleep Apnea Risk and Blood Chemistry Changes in the U.S. Population: National Health and Nutrition Examination Survey 2005-2008. The Internet Journal of Epidemiology. 2013 Volume 11 Number 2.